Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebselen for Mania/Hypomania in Bipolar Disorder
NCT03013400Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Oct 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ebselen in bipolar disorder (BD), sponsored by University of Oxford. Started Oct 2017; status: completed.
02
Drugs
ebselen
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT03013400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013400.